GlassScriptPhysician profile
Sandeep Gulati
NPI 1740292051
$156,253.37
in general payments reported to CMS, 2019-2025
81 companies · $40K in 2025
The $40K reported for 2025 was more than what 95% of Neurology (Psychiatry & Neurology) providers received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,274 · 2020: $3,490 · 2021: $27K · 2022: $21K · 2023: $26K · 2024: $34K · 2025: $40K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $72K · Food and Beverage: $19K · Honoraria: $5,500 · Travel and Lodging: $2,462 · Consulting Fee: $1,950 · Education: $19.61.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $71,865.25 |
| Food and Beverage | $18,644.33 |
| Honoraria | $5,500.00 |
| Travel and Lodging | $2,461.59 |
| Consulting Fee | $1,950.00 |
| Education | $19.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Emd Serono, INC. | $60,006.87 | 2019-2025 | Mavenclad, Mavenclad |
| Abbvie INC. | $51,221.79 | 2021-2024 | |
| Otsuka America Pharmaceutical, INC. | $8,335.50 | 2019-2025 | Rexulti, Abilify Maintena, Abilify Asimtufii |
| Axsome Therapeutics, INC. | $5,684.13 | 2025 | Symbravo |
| Allergan, INC. | $2,899.53 | 2019-2022 | |
| Teva Pharmaceuticals USA, INC. | $2,120.54 | 2019-2025 | Austedo Xr, Austedo Xr, Austedo |
| Amneal Pharmaceuticals LLC | $1,910.90 | 2019-2025 | Rytary, Crexont, Lyvispah |
| Novartis Pharmaceuticals Corporation | $1,851.32 | 2019-2025 | |
| Biogen, INC. | $1,704.60 | 2019-2025 | Tysabri, Vumerity, Plegridy |
| Lundbeck LLC | $1,578.95 | 2019-2025 | Vyepti |
| Pfizer INC. | $1,184.36 | 2019-2025 | |
| Sk Life Science, INC. | $1,100.54 | 2020-2025 | Xcopri |
| Alexion Pharmaceuticals, INC. | $1,073.78 | 2019-2025 | Ultomiris, Soliris |
| Lilly USA, LLC | $1,068.31 | 2019-2025 | Kisunla, Amyvid, Emgality |
| Celgene Corporation | $1,056.07 | 2021-2025 | Zeposia |
Show all 81 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mdd US Operations, LLC | $1,022.66 | 2019-2025 | Gocovri, Gocovri |
| Kyowa Kirin, INC. | $797.64 | 2019-2025 | Nourianz |
| Ucb, INC. | $776.17 | 2019-2024 | Nayzilam, Briviact |
| Avanir Pharmaceuticals, INC. | $740.48 | 2019-2022 | |
| Amgen INC. | $734.04 | 2019-2025 | Uplizna, Aimovig |
| Neurocrine Biosciences, INC. | $675.26 | 2019-2024 | Ingrezza, Ongentys |
| Adamas Pharmaceuticals, INC. | $624.98 | 2019-2021 | |
| Neurelis, INC. | $485.25 | 2022-2024 | Valtoco |
| Genentech USA, INC. | $458.45 | 2019-2025 | Ocrevus Zunovo, Ocrevus |
| Janssen Pharmaceuticals, INC | $445.34 | 2020-2023 | Ponvory |
| Sunovion Pharmaceuticals INC. | $442.65 | 2019-2022 | |
| Grifols USA, LLC | $399.15 | 2019-2025 | Gamunex-C |
| Argenx US, INC. | $375.86 | 2023-2025 | Vyvgart Hytrulo, Vyvgart |
| Biohaven Pharmaceuticals, INC. | $340.34 | 2020-2021 | |
| Alnylam Pharmaceuticals INC. | $335.32 | 2021-2024 | Onpattro |
| Biohaven Pharmaceutical Holding Company LTD. | $326.32 | 2022 | |
| Abbott Laboratories | $319.18 | 2020-2025 | Infinity |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $295.21 | 2020-2025 | Caplyta |
| Ge Healthcare | $268.04 | 2019-2023 | |
| Eisai INC. | $221.64 | 2023-2025 | |
| Acadia Pharmaceuticals INC | $191.22 | 2019-2025 | Daybue, Nuplazid |
| Takeda Pharmaceuticals U.S.A., INC. | $189.51 | 2023-2025 | Hyqvia |
| Mallinckrodt Enterprises LLC | $183.71 | 2019 | |
| Supernus Pharmaceuticals, INC. | $176.46 | 2019-2021 | |
| Csl Behring | $174.56 | 2019-2025 | Hizentra |
| Idorsia Pharmaceuticals US INC | $137.82 | 2022-2023 | Quviviq |
| Currax Pharmaceuticals LLC | $137.27 | 2020-2021 | |
| Genzyme Corporation | $136.70 | 2019-2022 | |
| Vanda Pharmaceuticals INC. | $131.61 | 2023-2025 | Fanapt, Hetlioz |
| Horizon Therapeutics Plc | $124.70 | 2021-2022 | |
| Acorda Therapeutics, INC | $108.29 | 2019-2021 | |
| Alfasigma USA, INC. | $103.73 | 2021-2022 | |
| Sumitomo Pharma America, INC. | $100.27 | 2023 | Aptiom |
| Scilex Pharmaceuticals INC. | $98.08 | 2021-2024 | Ztlido |
| Avion Pharmaceuticals | $92.98 | 2021-2023 | Dhivy |
| Tg Therapeutics, INC. | $90.25 | 2024-2025 | |
| Corium, LLC | $85.65 | 2023 | Adlarity |
| Medtronic USA, INC. | $84.81 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $83.56 | 2020-2021 | |
| Boston Scientific Corporation | $77.19 | 2019-2023 | Vercise |
| Life Molecular Imaging LTD | $74.00 | 2022-2025 | Neuraceq |
| Almatica Pharma LLC | $59.31 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $58.58 | 2021-2024 | |
| Catalyst Pharmaceuticals, INC. | $56.30 | 2019-2022 | |
| Baxter Healthcare | $54.61 | 2023 | Hillrom - Carnation Ambulatory Monitor |
| Medtronic, INC. | $47.58 | 2022-2024 | Percept PC Brainsense |
| Akcea Therapeutics, INC. | $44.43 | 2019-2021 | |
| Janssen Biotech, INC. | $40.19 | 2025 | |
| Xeris Pharmaceuticals, INC. | $39.52 | 2022-2025 | Keveyis |
| Averitas Pharma INC. | $36.57 | 2025 | Qutenza |
| Revance Therapeutics, INC. | $33.30 | 2024 | Daxxify |
| Alkermes, INC. | $32.07 | 2025 | Aristada, Lybalvi |
| Assertio Therapeutics, INC. | $31.96 | 2020 | |
| Harmony Biosciences LLC | $23.46 | 2025 | |
| Curonix LLC | $23.36 | 2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Kedrion Biopharma INC. | $22.96 | 2021 | |
| Tanabe Pharma America, INC. | $21.80 | 2022 | |
| Mallinckrodt Hospital Products INC. | $21.67 | 2020 | |
| Ipsen Biopharmaceuticals, INC | $21.00 | 2025 | Dysport |
| Upsher-Smith Laboratories LLC | $20.08 | 2021 | |
| Impel Pharmaceuticals INC. | $19.01 | 2023 | Trudhesa |
| Grt US Holding, INC. | $18.43 | 2021 | |
| Bausch Health US, LLC | $17.38 | 2019 | |
| Vertical Pharmaceuticals, LLC | $17.24 | 2019 | |
| Aprecia Pharmaceuticals, LLC | $14.81 | 2023 | Spritam |
| Promius Pharma LLC | $14.21 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sandeep Gulati listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.